毛细胞型星形细胞瘤形态学谱系扩展:整合组织病理学与多组学分析
该回顾性研究分析68例组织病理学特征模糊的胶质瘤,经DNA甲基化分型识别出6例毛细胞型星形细胞瘤(PA),均存在MAPK通路改变,随访11–38个月全部存活且无进展。结论强调DNA甲基化分型在准确分类中的关键作用,整合组织学与分子方法可避免误分类和过度治疗。
要点
- 组织病理学模糊的胶质瘤需行DNA甲基化分型以准确分类。
- DNA甲基化分型确诊的PA均存在MAPK通路改变。
- 整合组织学与分子诊断可避免误分类和过度治疗。
核心结论
- 形态学诊断在组织学异质性胶质瘤中存在局限,DNA甲基化分型对准确分类至关重要。
- 采用整合组织学与分子方法可避免误分类、防止过度治疗并改善预后评估。
研究设计与样本
- 回顾性分析68例组织病理学特征模糊的胶质瘤。
- 所有病例均行详细组织学、免疫组化、BRAF::KIAA融合FISH、二代测序、转录组分析和全基因组DNA甲基化分型。
- 复习临床与影像学资料并记录随访。
主要发现
- 68例组织病理学模糊的胶质瘤中,6例经DNA甲基化分型归类为毛细胞型星形细胞瘤(PA)。
- 所有PA病例的辅助分子分析均显示MAPK通路改变。
- 肿瘤发生于皮质、中线及幕下位置,组织形态学表现多样。
- 临床-影像学相关性支持惰性生物学行为,随访11–38个月所有患者存活且无进展。
临床怎么用
- 对组织病理学特征模糊的胶质瘤,应加做DNA甲基化分型以辅助准确分类。
- 整合组织学与分子诊断结果,避免仅凭形态学误判为高级别胶质瘤而过度治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pilocytic astrocytoma (PA) is a circumscribed low-grade glioma, typically defined by biphasic architecture, Rosenthal fibres, eosinophilic granular bodies, and MAPK pathway activation. However, PAs may sometimes display atypical morphologies, creating diagnostic dilemmas. DNA methylation profiling has emerged as a robust adjunct for resolving such ambiguity. METHODS: We retrospectively analysed 68 gliomas with ambiguous histopathology. All underwent integrated work-up, including detailed histology, immunohistochemistry, fluorescence in situ hybridisation (FISH) for BRAF::KIAA Fusion, next-generation sequencing, transcriptomic profiling, and genome-wide DNA methylation profiling. Clinical and radiological data were reviewed with follow-up documentation. RESULTS: Out of 68 gliomas with ambiguous histopathological features, six cases were classified as pilocytic astrocytoma (PA) based on DNA methylation profiling. Ancillary molecular analyses revealed MAPK pathway alterations in all cases. The tumours occurred across cortical, midline, and infratentorial locations, exhibiting varied histomorphological appearances. Clinico-radiological correlation supported an indolent biological behavior, with all patients remaining alive and progression-free at 11-38 months of follow-up. CONCLUSION: Our findings emphasise the limitations of morphology-based diagnosis in histologically heterogeneous gliomas and demonstrate the critical role of DNA methylation profiling in establishing accurate classification. Adoption of integrated histological and molecular approaches is essential to avoid misclassification, prevent overtreatment, and improve prognostic assessment. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Shahin M, Singh J, Mansoori S, et al. Expanding morphological spectrum of pilocytic astrocytomas: insights from integrated histopathological and multiomic profiling. J Neurooncol. 2025. PMID: 41191159. doi:10.1007/s11060-025-05326-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。